section 8
on 05 Apr 2019
Last Applicant/ Owned by
Windrush Court
Oxford OX4 6LT
GB
Serial Number
77767425 filed on 24th Jun 2009
Registration Number
4200422 registered on 04th Sep 2012
Filing Basis
1. intent to use
Disclaimer
NO DATA
Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic / angiogenic molecules, all for medical purposes in connection with the treatment of diseases of the eye; nucleic acid sequences and chemical reagents for medical purposes in connection with the treatment Read More
Enzymes for scientific and research purposes in connection with treatment of the eye; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories in connection with treatment for the eye; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research in connection with treatment for the eye; chemical reagents for use in medical science
Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic / angiogenic molecules, all for medical purposes in connection with the treatment of diseases of the eye; nucleic acid sequences and chemical reagents for medical purposes in connection with the treatment of diseases of the eye, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations in connection with the treatment of diseases of the eye
Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances in connection with the treatment of diseases of the eye; syringes and injectors for medical purposes in connection with the treatment of diseases of the eye
Scientific and medical research and development in connection with the treatment of diseases of the eye; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology in connection with the treatment of diseases of the eye; advisory services relating to research and development of gene therapy products all in connection with the treatment of diseases of the eye and specifically excluding analysis services
No 77767425
No Service Mark
No KILB.00007.T
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
05th Apr 2019 | CANCELLED SEC. 8 (6-YR) |
08th Jun 2018 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
08th Jun 2018 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
04th Sep 2017 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
14th Mar 2016 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
14th Mar 2016 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
26th Sep 2012 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
22nd Sep 2012 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
17th Sep 2012 | TEAS SECTION 7 REQUEST RECEIVED |
04th Sep 2012 | REGISTERED-PRINCIPAL REGISTER |